T. Rowe Price Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.1B | Sell |
|
|||||
|
2025
Q1 | $15.8B | Sell |
|
|||||
|
2024
Q4 | $16.1B | Sell |
|
|||||
|
2024
Q3 | $18.5B | Buy |
|
|||||
|
2024
Q2 | $18.7B | Buy |
|
|||||
|
2024
Q1 | $16B | Sell |
|
|||||
|
2023
Q4 | $12.7B | Sell |
|
|||||
|
2023
Q3 | $11.9B | Sell |
|
|||||
|
2023
Q2 | $11.3B | Buy |
|
|||||
|
2023
Q1 | $7.8B | Buy |
|
|||||
|
2022
Q4 | $8.29B | Sell |
|
|||||
|
2022
Q3 | $8.05B | Buy |
|
|||||
|
2022
Q2 | $6.62B | Sell |
|
|||||
|
2022
Q1 | $5.99B | Sell |
|
|||||
|
2021
Q4 | $6.96B | Sell |
|
|||||
|
2021
Q3 | $6.99B | Buy |
|
|||||
|
2021
Q2 | $6.14B | Buy |
|
|||||
|
2021
Q1 | $4.89B | Buy |
|
|||||
|
2020
Q4 | $2.04B | Buy |
|
|||||
|
2020
Q3 | $1.19B | Buy |
|
|||||
|
2020
Q2 | $1.04B | Buy |
|
|||||
|
2020
Q1 | $595M | Buy |
|
|||||
|
2019
Q4 | $550M | Sell |
|
|||||
|
2019
Q3 | $545M | Sell |
|
|||||
|
2019
Q2 | $955M | Sell |
|
|||||
|
2019
Q1 | $2.92B | Buy |
|
|||||
|
2018
Q4 | $2.28B | Buy |
|
|||||
|
2018
Q3 | $593M | Buy |
|
|||||
|
2018
Q2 | $233M | Sell |
|
|||||
|
2018
Q1 | $299M | Sell |
|
|||||
|
2017
Q4 | $381M | Sell |
|
|||||
|
2017
Q3 | $391M | Sell |
|
|||||
|
2017
Q2 | $457M | Sell |
|
|||||
|
2017
Q1 | $626M | Buy |
|
|||||
|
2016
Q4 | $514M | Sell |
|
|||||
|
2016
Q3 | $1.05B | Sell |
|
|||||
|
2016
Q2 | $1.17B | Sell |
|
|||||
|
2016
Q1 | $1.17B | Sell |
|
|||||
|
2015
Q4 | $1.59B | Buy |
|
|||||
|
2015
Q3 | $1.57B | Sell |
|
|||||
|
2015
Q2 | $1.64B | Sell |
|
|||||
|
2015
Q1 | $1.5B | Sell |
|
|||||
|
2014
Q4 | $1.67B | Buy |
|
|||||
|
2014
Q3 | $1.09B | Buy |
|
|||||
|
2014
Q2 | $99.9M | Buy |
|
|||||
|
2014
Q1 | $93.6M | Sell |
|
|||||
|
2013
Q4 | $176M | Sell |
|
|||||
|
2013
Q3 | $176M | Sell |
|
|||||
|
2013
Q2 | $183M | Buy |
|